Research Progress on Prognostic Indicators of Neoadjuvant Therapy for HER-2 Positive Breast Cancer
-
Published:2024
Issue:03
Volume:14
Page:374-381
-
ISSN:2161-8712
-
Container-title:Advances in Clinical Medicine
-
language:
-
Short-container-title:ACM
Publisher
Hans Publishers
Reference48 articles.
1. Cancer statistics for the year 2020: An overview
2. 杨壹羚, 宋园明, 薛慧琴, 孙卉, 李崖青, 钱晓龙, 焦娇, 李鲲鹏, 张恒, 郭晓静. 人表皮生长因子受体2瘤内异质性乳腺癌的病理学特征和免疫微环境[J]. 中华肿瘤杂志, 2023, 45(2): 165-169.
3. P95 HER2 fragments and breast cancer outcome
4. Human Breast Cancer: Correlation of Relapse and Survival with Amplification of the HER-2/
neu
Oncogene
5. HER3, p95HER2, and HER2 protein expression levels define multiple subtypes of HER2-positive metastatic breast cancer